| __timestamp | Amneal Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 179279000 |
| Thursday, January 1, 2015 | 367054000 | 186359000 |
| Friday, January 1, 2016 | 420770000 | 171785000 |
| Sunday, January 1, 2017 | 507476000 | 208136000 |
| Monday, January 1, 2018 | 946588000 | 198405000 |
| Tuesday, January 1, 2019 | 1273376000 | 224169000 |
| Wednesday, January 1, 2020 | 1364130000 | 245044000 |
| Friday, January 1, 2021 | 1324696000 | 252314000 |
| Saturday, January 1, 2022 | 1427596000 | 268225000 |
| Sunday, January 1, 2023 | 1573042000 | 304629000 |
| Monday, January 1, 2024 | 324203000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. From 2014 to 2023, Amneal Pharmaceuticals, Inc. has seen a significant rise in its cost of revenue, growing by approximately 368% from 2014 to 2023. This upward trend reflects Amneal's expanding operations and market reach. In contrast, Taro Pharmaceutical Industries Ltd. has maintained a more stable cost structure, with a modest increase of around 70% over the same period. This stability suggests a focus on efficiency and cost management.
These insights highlight the differing strategies of two major players in the pharmaceutical industry, offering a glimpse into their operational priorities.
Cost of Revenue Comparison: AstraZeneca PLC vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Pfizer Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Cost of Revenue Trends: Incyte Corporation vs Amneal Pharmaceuticals, Inc.
Viatris Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Insmed Incorporated and Taro Pharmaceutical Industries Ltd.'s Expenses
Cost of Revenue: Key Insights for Jazz Pharmaceuticals plc and Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Cytokinetics, Incorporated vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Vericel Corporation and Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.